Clinical Trial: Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Brief Summary: To investigate the efficacy and safety of PARIET twice daily (b.i.d.) in patients with Proton Pump Inhibitor-resistant reflux esophagitis